<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006895.ref012">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Yang</surname>
   <given-names>WL</given-names>
  </name>, 
  <name>
   <surname>Kouyos</surname>
   <given-names>RD</given-names>
  </name>, 
  <name>
   <surname>BÃ¶ni</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Yerly</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Klimkait</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Aubert</surname>
   <given-names>V</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds</article-title>. 
  <source>PLoS Pathog</source>. 
  <year>2015</year>;
  <volume>11</volume>(
  <issue>3</issue>):
  <fpage>e1004722</fpage>
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1004722" xmlns:xlink="http://www.w3.org/1999/xlink">10.1371/journal.ppat.1004722</ext-link>
  </comment>
  <?supplied-pmid 25798934?>
  <pub-id pub-id-type="pmid">25798934</pub-id>
 </mixed-citation>
</ref>
